Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

Página do item simplificado
dc.contributor.authorGomes, Luis Eduardo Miani
dc.contributor.authorda Silva, Francesca Aparecida Ramos
dc.contributor.authorPascoal, Lívia Bitencourt
dc.contributor.authorRicci, Renato Lazarin
dc.contributor.authorNogueira, Guilherme
dc.contributor.authorCamargo, Michel Gardere
dc.contributor.authorde Lourdes Setsuko Ayrizono, Maria
dc.contributor.authorFagundes, João José
dc.contributor.authorLeal, Raquel Franco
dc.date.accessioned2024-05-17T18:31:03Z
dc.date.available2024-05-17T18:31:03Z
dc.date.issued2019
dc.identifier.doi10.6061/clinics/2019/e1517
dc.identifier.issn1807-5932
dc.identifier.otherS1807-59322019000100405-scl
dc.identifier.urihttps://repositorio-aptaregional.agricultura.sp.gov.br/handle/123456789/2016
dc.relation.ispartofClinics
dc.titleAuthors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
dc.typeArtigos
oaire.citation.volume74

Arquivos

Licença do Pacote
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição:
Baixar

Coleções

Artigos